Literature DB >> 26474773

Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis.

Young Ho Lee1, Sang-Cheol Bae2.   

Abstract

The objective of the study was to determine by meta-analysis whether polymorphisms of the gene encoding peptidylarginine deiminase 4 (PADI4) are associated with susceptibility to rheumatoid arthritis (RA). A literature review was conducted to identify data sets that described analyses of genetic association between PADI4 polymorphisms and RA. Data sets were collated and a meta-analysis was performed, with a specific focus on associations within Caucasian and Asian populations. A total of 15,947 RA cases and 22,696 controls that were taken from 28 studies in 24 papers were included in this study. Meta-analysis showed a significant association between allele 2 of the PADI4_94 polymorphism and RA in the overall population (odds ratio [OR] = 1.155, 95 % confidence interval [CI] = 1.069-1.249, p = 2.7 × 10(-5)). Stratification by ethnicity revealed an association between PADI4_94 allele 2 and RA in Asians (OR = 1.273, 95 % CI = 1.193-1.359, p < 1.0 × 10(-9)), but not in Caucasians (OR = 1.024, 95 % CI = 0.973-1.078, p = 0.358). However, meta-analysis using homozygote contrast showed an association between PADI4_94 allele 2 and RA in both Asians (OR = 2.311, 95 % CI = 1.1.858-2.875, p < 1.0 × 10(-9)) and Caucasians (OR = 1.523, 95 % CI = 1.157-2.004, p = 0.008). Meta-analysis also revealed an association between allele 2 of the PADI4_104 polymorphism and RA in both Asians (OR = 1.547, 95 % CI = 1.247-1.919, p = 7.1 × 10(-6)) and Caucasians (OR = 1.096, 95 % CI = 1.025-1.172, p = 0.008). Finally, meta-analysis showed an association between allele 2 of the PADI4_92 polymorphism and RA in Asians (OR = 1.263, 95 % CI = 1.153-1.384, p = 5.8 × 10(-8)), but not in Caucasians (OR = 1.123, 95 % CI = 0.980-1.287, p = 0.095). Meta-analysis indicated no association between allele 2 of either the PADI4_90 or PADI4_89 polymorphisms and RA in Asians. This meta-analysis revealed that the PADI4_94 and PADI_104 polymorphisms are associated with susceptibility to RA in Asians and Caucasians, and that the PADI4_92 polymorphism is associated with susceptibility to RA in Asians, but not in Caucasians.

Entities:  

Keywords:  Meta-analysis; PADI4; Polymorphism; Rheumatoid arthritis

Mesh:

Substances:

Year:  2015        PMID: 26474773     DOI: 10.1007/s10067-015-3098-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  36 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Lack of association between PADI4 polymorphisms and rheumatoid arthritis in the Tunisian population.

Authors:  Hana Ben Hassine; Ramzi Zemni; Elyes Bouagina; Hala Zaglaoui; Hosni Ben Fradj; Foued Slama; Jalel Boukadida; Rim Sghiri
Journal:  Joint Bone Spine       Date:  2012-03-28       Impact factor: 4.929

3.  Genome scan meta-analysis of rheumatoid arthritis.

Authors:  S J Choi; Y H Rho; J D Ji; G G Song; Y H Lee
Journal:  Rheumatology (Oxford)       Date:  2005-11-08       Impact factor: 7.580

4.  [Association of polymorphisms of PTPN22 and PADI4 genes with rheumatoid arthritis in Yunnan].

Authors:  Qian Li; Ke-qin Lin; Qin Li; Jing Wang; Juan Yu; Liang Yu; Wei Yi; Xiao-qin Huang; Jia-you Chu; Zhao-qing Yang
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2013-02

Review 5.  Autoantigenic posttranslational modifications of proteins: does it apply to rheumatoid arthritis?

Authors:  ZhiJie Zhou; Henri-André Ménard
Journal:  Curr Opin Rheumatol       Date:  2002-05       Impact factor: 5.006

6.  Association of single nucleotide polymorphisms (SNPs) of PADI4 gene with rheumatoid arthritis (RA) in Indian population.

Authors:  Kalpana Panati; Sarvajeet Pal; K V Rao; Vudem D Reddy
Journal:  Genes Genet Syst       Date:  2012       Impact factor: 1.517

7.  Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis.

Authors:  Jinluo Cheng; Hui Zhang; Chao Zhuang; Ruiping Liu
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

8.  PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.

Authors:  Sai Hou; Guo-Peng Gao; Xiu-Jun Zhang; Liang Sun; Wen-Jia Peng; Han-Fei Wang; Xiao-Jiao Ge; Wei Huang; Ye-Huan Sun
Journal:  Mod Rheumatol       Date:  2012-05-03       Impact factor: 3.023

9.  Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.

Authors:  Robert M Plenge; Leonid Padyukov; Elaine F Remmers; Shaun Purcell; Annette T Lee; Elizabeth W Karlson; Frederick Wolfe; Daniel L Kastner; Lars Alfredsson; David Altshuler; Peter K Gregersen; Lars Klareskog; John D Rioux
Journal:  Am J Hum Genet       Date:  2005-11-01       Impact factor: 11.025

10.  PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.

Authors:  Young Ho Lee; Young Hee Rho; Seong Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2007-01-31       Impact factor: 3.580

View more
  16 in total

Review 1.  The relationship of PADI4_94 polymorphisms with the morbidity of rheumatoid arthritis in Caucasian and Asian populations: a meta-analysis and system review.

Authors:  Chao Lu; Ke Xu; Hao Guo; Kan Peng; Zhi Yang; Yang Quan Hao; Peng Xu
Journal:  Clin Rheumatol       Date:  2018-01-04       Impact factor: 2.980

2.  Genetic Epidemiology of Complex Phenotypes.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Methods Mol Biol       Date:  2021

3.  Phenotypic interpretation of complex chromosomal rearrangements informed by nucleotide-level resolution and structural organization of chromatin.

Authors:  Cinthya J Zepeda-Mendoza; Alexandra Bardon; Tammy Kammin; David J Harris; Helen Cox; Claire Redin; Zehra Ordulu; Michael E Talkowski; Cynthia C Morton
Journal:  Eur J Hum Genet       Date:  2018-01-10       Impact factor: 4.246

4.  The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis.

Authors:  Marek Ciesla; Bogdan Kolarz; Dorota Darmochwal-Kolarz
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

5.  Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis.

Authors:  Han Cen; Hua Huang; Li-Na Zhang; Li-Ya Liu; Li Zhou; Xia-Fei Xin; Ren-Jie Zhuo
Journal:  Clin Rheumatol       Date:  2016-07-16       Impact factor: 2.980

Review 6.  The B cell response to citrullinated antigens in the development of rheumatoid arthritis.

Authors:  Hans Ulrich Scherer; Tom W J Huizinga; Gerhard Krönke; Georg Schett; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2018-02-08       Impact factor: 20.543

7.  Meta-analysis of the association between PADI4 -92C/G polymorphism and rheumatoid arthritis in the Chinese population.

Authors:  Z Y Guo; J X Zhang; M Wu; Y F Mei; X J Lin; C Bu; Y Xie; J Wang
Journal:  Braz J Med Biol Res       Date:  2017-08-17       Impact factor: 2.590

8.  PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.

Authors:  Kaori Hisa; Masakatsu D Yanagimachi; Takuya Naruto; Takako Miyamae; Masako Kikuchi; Rhoki Hara; Tomoyuki Imagawa; Shumpei Yokota; Masaaki Mori
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

9.  Peptidylarginine deiminase 4 -104C/T polymorphism and risk of rheumatoid arthritis: A pooled analysis based on different populations.

Authors:  Jiong Hua; Weijie Huang
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

Review 10.  Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response.

Authors:  Dmitry S Mikhaylenko; Marina V Nemtsova; Irina V Bure; Ekaterina B Kuznetsova; Ekaterina A Alekseeva; Vadim V Tarasov; Alexander N Lukashev; Marina I Beloukhova; Andrei A Deviatkin; Andrey A Zamyatnin
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.